TRANSLOKA BIO PRIVATE LIMITED

In their own words

TRANSLOKA BIO PRIVATE LIMITED The business focuses on research, development, and commercialization of advanced biotechnology products, with core expertise in gene therapy and tRNA-based therapeutics. Gene therapy aims to treat or cure genetic disorders by delivering functional genes or editing defective DNA using viral and non-viral delivery systems. tRNA-based therapeutics is an emerging platform that restores production of full-length proteins in patients with nonsense mutations, offering hope for rare diseases like cystic fibrosis and muscular dystrophy.Our R&D covers target identification, vector design, preclinical testing, and GMP manufacturing. We work on optimizing delivery, reducing immunogenicity, and improving efficacy through novel lipid nanoparticles and AAV engineering. Commercialization includes clinical trial management, regulatory approvals from CDSCO, USFDA, EMA, and building scalable manufacturing partnerships. Allied activities include IP development, bioinformatics, biomarker discovery, and collaborations with hospitals and academic institutions for translational research. We also provide CRO services, skill development programs, and regulatory consultancy. This integrated model drives innovation by moving science from lab to patient, improves outcomes through precision medicine, and scales via platform technologies that can be adapted for multiple indications. The goal is to make next-generation biotherapeutics accessible and affordable while building a globally competitive biotech enterprise from India

Written by the company on its public Startup India profile. Not verified by us.